H. M. Shaw

2.8k total citations
56 papers, 2.1k citations indexed

About

H. M. Shaw is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, H. M. Shaw has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in H. M. Shaw's work include Cutaneous Melanoma Detection and Management (39 papers), CAR-T cell therapy research (8 papers) and Cutaneous lymphoproliferative disorders research (8 papers). H. M. Shaw is often cited by papers focused on Cutaneous Melanoma Detection and Management (39 papers), CAR-T cell therapy research (8 papers) and Cutaneous lymphoproliferative disorders research (8 papers). H. M. Shaw collaborates with scholars based in Australia, United Kingdom and United States. H. M. Shaw's co-authors include G. W. Milton, William H. McCarthy, V. J. McGovern, G. A. Farago, W. H. McCarthy, John F. Thompson, T Heath, G. W. Milton, Charles M. Balch and Seng-Jaw Soong and has published in prestigious journals such as Cancer, Gut and British Journal of Cancer.

In The Last Decade

H. M. Shaw

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. M. Shaw Australia 26 1.8k 672 509 417 277 56 2.1k
A J Sober United States 25 1.5k 0.9× 649 1.0× 410 0.8× 458 1.1× 361 1.3× 46 2.1k
Stephen L. Gumport United States 21 1.0k 0.6× 416 0.6× 299 0.6× 309 0.7× 135 0.5× 45 1.3k
Jerry Marsden United Kingdom 19 862 0.5× 403 0.6× 420 0.8× 524 1.3× 251 0.9× 32 1.6k
Ulrike Keim Germany 19 1.4k 0.8× 527 0.8× 583 1.1× 422 1.0× 313 1.1× 44 1.8k
Maria Antonietta Pizzichetta Italy 21 1.1k 0.6× 510 0.8× 537 1.1× 539 1.3× 60 0.2× 68 1.8k
A. J. Cochran United States 19 534 0.3× 349 0.5× 163 0.3× 89 0.2× 380 1.4× 40 1.1k
François Salès Belgium 21 1.4k 0.8× 958 1.4× 218 0.4× 131 0.3× 783 2.8× 46 1.9k
Antonella Romanini Italy 23 788 0.4× 436 0.6× 203 0.4× 89 0.2× 305 1.1× 73 1.7k
Andrea Forschner Germany 24 1.2k 0.7× 616 0.9× 130 0.3× 105 0.3× 392 1.4× 107 1.7k
Thomas Jouary France 27 786 0.4× 782 1.2× 367 0.7× 649 1.6× 488 1.8× 83 2.1k

Countries citing papers authored by H. M. Shaw

Since Specialization
Citations

This map shows the geographic impact of H. M. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. M. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. M. Shaw more than expected).

Fields of papers citing papers by H. M. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. M. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. M. Shaw. The network helps show where H. M. Shaw may publish in the future.

Co-authorship network of co-authors of H. M. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of H. M. Shaw. A scholar is included among the top collaborators of H. M. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. M. Shaw. H. M. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Accortt, Neil A., H. M. Shaw, Marjorie H. Colman, et al.. (2008). Follow-up schedules after treatment for malignant melanoma. British journal of surgery. 95(11). 1401–1407. 63 indexed citations
2.
Shaw, H. M., et al.. (2007). Detection of second primary cutaneous melanomas. European Journal of Surgical Oncology. 34(5). 587–592. 18 indexed citations
3.
Thompson, John F. & H. M. Shaw. (2006). BENEFITS OF SENTINEL NODE BIOPSY FOR MELANOMA: A REVIEW BASED ON INTERIM RESULTS OF THE FIRST MULTICENTER SELECTIVE LYMPHADENECTOMY TRIAL. ANZ Journal of Surgery. 76(3). 100–103. 9 indexed citations
4.
Shaw, H. M., et al.. (1999). PRIMARY MUCOSAL AND GLANS PENIS MELANOMAS: THE SYDNEY MELANOMA UNIT EXPERIENCE. Australian and New Zealand Journal of Surgery. 69(2). 121–126. 22 indexed citations
5.
Spatz, Alan, H. M. Shaw, Kerry A. Crotty, John F. Thompson, & S. McCarthy. (1998). Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm). Histopathology. 33(5). 406–413. 30 indexed citations
6.
Uren, R F, R Howman-Giles, John F. Thompson, et al.. (1994). Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Research. 4(6). 395–399. 106 indexed citations
7.
McCarthy, S W, Kerry A. Crotty, A.A. Palmer, et al.. (1994). Cutaneous malignant melanoma in teenagers. Histopathology. 24(5). 453–461. 16 indexed citations
8.
Rivers, Jason K., et al.. (1992). Clinical aspects of hereditary melanoma in Australia. Cytogenetic and Genome Research. 59(2-3). 170–172. 8 indexed citations
9.
Rivers, Jason K., S. McCarthy, H. M. Shaw, et al.. (1991). patients with thick melanomas surviving at least 10 years: histological, cytometric and HLA analyses. Histopathology. 18(4). 339–346. 11 indexed citations
10.
Kefford, Richard, et al.. (1991). Hereditary melanoma in Australia variable association with dysplastic nevi and. Cancer Genetics and Cytogenetics. 51(1). 45–55. 55 indexed citations
11.
Shaw, H. M., S W McCarthy, W. H. McCarthy, John F. Thompson, & G. W. Milton. (1989). Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases. Histopathology. 15(3). 257–265. 52 indexed citations
12.
Zardawi, Ibrahim M., et al.. (1988). DNA ploidy in thin melanoma. Pathology. 20(3). 243–246. 5 indexed citations
13.
Milton, G. W., H. M. Shaw, & William H. McCarthy. (1985). RESECTION MARGINS FOR MELANOMA. Australian and New Zealand Journal of Surgery. 55(3). 225–226. 39 indexed citations
14.
Milton, G. W., H. M. Shaw, & William H. McCarthy. (1985). SUBUNGUAL MALIGNANT MELANOMA: A DISEASE ENTITY SEPARATE FROM OTHER FORMS OF CUTANEOUS MELANOMA. Australasian Journal of Dermatology. 26(2). 61–64. 17 indexed citations
15.
McGovern, V. J., H. M. Shaw, G. W. Milton, & William H. McCarthy. (1982). Ulceration and prognosis in cutaneous malignant melanoma. Histopathology. 6(4). 399–407. 63 indexed citations
16.
Shaw, H. M., V. J. McGovern, G. W. Milton, & G. A. Farago. (1981). CUTANEOUS MALIGNANT MELANOMA: OCCUPATION AND PROGNOSIS. The Medical Journal of Australia. 1(1). 37–38. 10 indexed citations
17.
Shaw, H. M., G. W. Milton, G. A. Farago, & W. H. McCarthy. (1978). Endocrine influences on survival from malignant melanoma. Cancer. 42(2). 669–677. 115 indexed citations
18.
Shaw, H. M. & T Heath. (1974). The gallbladder of the guinea pig: Its concentrating and contractile abilities. Comparative Biochemistry and Physiology Part A Physiology. 49(2). 231–240. 2 indexed citations
19.
Shaw, H. M. & T Heath. (1973). THE PHASES OF PANCREATIC SECRETION IN RATS. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences. 58(3). 229–237. 8 indexed citations
20.
Shaw, H. M.. (1956). THE TREATMENT OF FRACTURES BY INTRAMEDULLARY NAILING. The Medical Journal of Australia. 1(2). 41–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026